Europe Drug Device Combination Products Market Size & Outlook
Related Markets
Europe drug device combination products market highlights
- The Europe drug device combination products market generated a revenue of USD 38,787.2 million in 2023.
- The market is expected to grow at a CAGR of 9.6% from 2024 to 2030.
- In terms of segment, transdermal patches was the largest revenue generating product in 2023.
- Drug Eluting Stents is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, Denmark is expected to register the highest CAGR from 2024 to 2030.
Europe data book summary
| Market revenue in 2023 | USD 38,787.2 million |
| Market revenue in 2030 | USD 73,546.7 million |
| Growth rate | 9.6% (CAGR from 2023 to 2030) |
| Largest segment | Transdermal patches |
| Fastest growing segment | Drug Eluting Stents |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Photodynamic Therapy Devices, Transdermal Patches, Wound Care Products, Infusion Pumps, Orthopedic Combination Products, Drug Eluting Stents, Inhalers, Antimicrobial Catheters |
| Key market players worldwide | Abbott Laboratories, Terumo Corp, Stryker Corp, Viatris Inc, Medtronic PLC, Boston Scientific Corp, Novartis AG ADR, Becton Dickinson & Co, Teleflex Inc, W L Gore & Associates |
Other key industry trends
- In terms of revenue, Europe region accounted for 28.0% of the global drug device combination products market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 66,066.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Drug Device Combination Products Market Scope
Drug Device Combination Products Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Viatris Inc | View profile | 38000 | 1000 Mylan Boulevard, Canonsburg, PA, United States, 15317 | https://www.viatris.com |
| W L Gore & Associates | View profile | 5001-10000 | Newark, Delaware, United States, North America | https://www.gore-tex.com/en_uk |
| Terumo Corp | View profile | 30207 | 2-44-1 Hatagaya, Shibuya-ku, Tokyo, Japan, 151-0072 | https://www.terumo.com |
| Teleflex Inc | View profile | 14500 | 550 East Swedesford Road, Suite 400, Wayne, PA, United States, 19087 | https://www.teleflex.com |
| Boston Scientific Corp | View profile | 48000 | 300 Boston Scientific Way, Marlborough, MA, United States, 01752-1234 | https://www.bostonscientific.com |
| Stryker Corp | View profile | 52000 | 1941 Stryker Way, Portage, MI, United States, 49002 | https://www.stryker.com |
| Medtronic PLC | View profile | 95000 | Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 | https://www.medtronic.com |
| Becton Dickinson & Co | View profile | 73000 | 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880 | https://www.bd.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
Europe drug device combination products market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug device combination products market will help companies and investors design strategic landscapes.
Transdermal patches was the largest segment with a revenue share of 22.96% in 2023. Horizon Databook has segmented the Europe drug device combination products market based on photodynamic therapy devices, transdermal patches, wound care products, infusion pumps, orthopedic combination products, drug eluting stents, inhalers, antimicrobial catheters covering the revenue growth of each sub-segment from 2018 to 2030.
Europe held the second-largest revenue share of the global drug device combination products market in 2023. The UK, France, Germany, Italy, and Spain are considered to be the major markets in this region. Growth in the region can be attributed to the increasing prevalence of chronic diseases, such as diabetes, pain, & respiratory conditions, which require regular medication.
According to the International Diabetes Federation, around 56.6 million adults in Europe were living with diabetes in 2022, and the number is expected to surge over the coming decade, highlighting the growing patient population. This is expected to drive the demand for drug-device combination products to improve medication compliance and overall treatment outcomes. Moreover, patients are increasingly looking for treatment options that are easy to use, painless, and noninvasive.
Reasons to subscribe to Europe drug device combination products market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe drug device combination products market databook
-
Our clientele includes a mix of drug device combination products market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe drug device combination products market , including forecasts for subscribers. This continent databook contains high-level insights into Europe drug device combination products market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe drug device combination products market size, by country, 2018-2030 (US$M)
Europe Drug Device Combination Products Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
